Lexicon Pharmaceuticals, Inc. (LXRX)
2.325
+0.02
(+1.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.325
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Total Liabilities (Quarterly) : 75.54M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 75.54M |
| March 31, 2026 | 65.96M |
| December 31, 2025 | 77.45M |
| September 30, 2025 | 85.77M |
| June 30, 2025 | 96.14M |
| March 31, 2025 | 174.64M |
| December 31, 2024 | 152.47M |
| September 30, 2024 | 142.61M |
| June 30, 2024 | 133.38M |
| March 31, 2024 | 128.35M |
| December 31, 2023 | 136.32M |
| September 30, 2023 | 136.97M |
| June 30, 2023 | 130.36M |
| March 31, 2023 | 74.67M |
| December 31, 2022 | 77.18M |
| September 30, 2022 | 47.67M |
| June 30, 2022 | 41.50M |
| March 31, 2022 | 43.48M |
| December 31, 2021 | 23.31M |
| September 30, 2021 | 35.73M |
| June 30, 2021 | 34.44M |
| March 31, 2021 | 40.71M |
| December 31, 2020 | 47.42M |
| September 30, 2020 | 91.29M |
| June 30, 2020 | 333.23M |
| Date | Value |
|---|---|
| March 31, 2020 | 315.79M |
| December 31, 2019 | 304.76M |
| September 30, 2019 | 279.88M |
| June 30, 2019 | 298.03M |
| March 31, 2019 | 304.20M |
| December 31, 2018 | 315.05M |
| September 30, 2018 | 339.59M |
| June 30, 2018 | 338.01M |
| March 31, 2018 | 360.62M |
| December 31, 2017 | 389.32M |
| September 30, 2017 | 251.11M |
| June 30, 2017 | 257.20M |
| March 31, 2017 | 261.66M |
| December 31, 2016 | 786.62M |
| September 30, 2016 | 331.76M |
| June 30, 2016 | 340.80M |
| March 31, 2016 | 358.46M |
| December 31, 2015 | 782.59M |
| September 30, 2015 | 193.20M |
| June 30, 2015 | 184.49M |
| March 31, 2015 | 187.08M |
| December 31, 2014 | 599.78M |
| September 30, 2014 | 109.70M |
| June 30, 2014 | 107.40M |
| March 31, 2014 | 102.82M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Viatris, Inc. | 20.78B |
| Pfizer Inc. | 115.64B |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 182.93M |
| Veru, Inc. | 8.651M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 250.06M |
| Shareholders Equity (Quarterly) | 174.52M |
| Debt to Equity Ratio | 0.3394 |
| Current Ratio | 13.37 |
| Net Debt Paydown Yield | 0.88% |